Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA ZYDUS LIFESCIENCES AUROBINDO PHARMA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 12.3 17.8 69.2% View Chart
P/BV x 1.3 2.2 62.0% View Chart
Dividend Yield % 1.6 0.7 232.7%  

Financials

 AUROBINDO PHARMA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
ZYDUS LIFESCIENCES
Mar-22
AUROBINDO PHARMA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs1,064674 157.9%   
Low Rs584331 176.5%   
Sales per share (Unadj.) Rs400.3149.1 268.5%  
Earnings per share (Unadj.) Rs45.722.7 201.2%  
Cash flow per share (Unadj.) Rs64.929.7 218.7%  
Dividends per share (Unadj.) Rs9.002.50 360.0%  
Avg Dividend yield %1.10.5 219.5%  
Book value per share (Unadj.) Rs419.4166.1 252.6%  
Shares outstanding (eoy) m585.941,023.74 57.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.13.4 61.1%   
Avg P/E ratio x18.022.1 81.5%  
P/CF ratio (eoy) x12.716.9 75.0%  
Price / Book Value ratio x2.03.0 64.9%  
Dividend payout %19.711.0 179.0%   
Avg Mkt Cap Rs m482,799514,277 93.9%   
No. of employees `000NANA-   
Total wages/salary Rs m34,50921,777 158.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,555152,652 153.7%  
Other income Rs m3,2262,354 137.0%   
Total revenues Rs m237,781155,006 153.4%   
Gross profit Rs m42,56634,427 123.6%  
Depreciation Rs m11,2657,130 158.0%   
Interest Rs m4861,270 38.3%   
Profit before tax Rs m34,04028,381 119.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2565,117 141.8%   
Profit after tax Rs m26,78423,264 115.1%  
Gross profit margin %18.122.6 80.5%  
Effective tax rate %21.318.0 118.2%   
Net profit margin %11.415.2 74.9%  
BALANCE SHEET DATA
Current assets Rs m181,227122,614 147.8%   
Current liabilities Rs m81,56078,394 104.0%   
Net working cap to sales %42.529.0 146.7%  
Current ratio x2.21.6 142.1%  
Inventory Days Days2593 27.0%  
Debtors Days Days6280 78.2%  
Net fixed assets Rs m155,104144,382 107.4%   
Share capital Rs m5861,024 57.2%   
"Free" reserves Rs m245,174168,972 145.1%   
Net worth Rs m245,760169,996 144.6%   
Long term debt Rs m2,4923,621 68.8%   
Total assets Rs m336,331266,996 126.0%  
Interest coverage x71.023.3 304.0%   
Debt to equity ratio x00 47.6%  
Sales to assets ratio x0.70.6 122.0%   
Return on assets %8.19.2 88.2%  
Return on equity %10.913.7 79.6%  
Return on capital %13.917.1 81.4%  
Exports to sales %31.10-   
Imports to sales %11.914.3 83.2%   
Exports (fob) Rs m72,862NA-   
Imports (cif) Rs m27,96521,869 127.9%   
Fx inflow Rs m77,24563,065 122.5%   
Fx outflow Rs m31,52421,869 144.1%   
Net fx Rs m45,72141,196 111.0%   
CASH FLOW
From Operations Rs m50,16521,041 238.4%  
From Investments Rs m-32,11611,544 -278.2%  
From Financial Activity Rs m-29,693-8,683 342.0%  
Net Cashflow Rs m-11,67423,729 -49.2%  

Share Holding

Indian Promoters % 48.8 74.9 65.1%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 38.0 14.9 255.4%  
FIIs % 20.7 2.9 724.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 25.1 191.8%  
Shareholders   359,684 455,624 78.9%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   DR. REDDYS LAB    SUN PHARMA    CIPLA    LUPIN    SANOFI INDIA    



Today's Market

Indian Share Markets End Flat; IT and FMCG Stocks Witness Selling(Closing)

Indian share markets traded in a rangebound manner throughout the day to end on a flat note.